Clinical Trial

Employment Support After Hematopoietic Stem Cell Transplantation

Study acronym: WorkS
Recruiting
View on ClinicalTrials.gov →
Summary
This is a feasibility study of a Work Support (WorkS) intervention designed to ameliorate employment challenges for people preparing to return to work after allogeneic stem cell transplantation. The aim of this study is to evaluate "proof of concept" by: 1. examining the feasibility and acceptability of the WorkS intervention and the study procedures, and 2. exploring the preliminary effects of WorkS for improving patient-reported return-to-work self-efficacy, work status, quality of life, and financial toxicity.
Protocol Amendment History 2 amendments
This ClinicalTrials.gov record has been amended 2 times since 2024-07-02; most recent amendment 2025-12-12.
Status change: Not Yet Recruiting → Recruiting 2024-11-18
Trial Details
NCT Number NCT06494423
Lead Sponsor MGH Institute of Health Professions
Collaborators: Massachusetts General Hospital
Conditions Hematopoietic Stem Cell Transplantation
Enrollment 35 participants
Start Date 2024-07-31
Primary Completion 2027-12-31 (estimated)
Study Completion 2027-12-31 (estimated)
Updated on ClinicalTrials.gov 2025-12-19